rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Novartis India

Rediff.com  »  News  »   Novartis India

  News for Novartis India

  • Business

Novartis-GSK-Eli Lilly deal may affect Indian market

Swiss drug major Novartis’ multi-billion-dollar overhaul through deals with two multinational firms -- GlaxoSmithKline and Eli Lilly -- is likely to have an impact on the Indian market, too,......

Govt refutes Novartis' allegations on patents

Tearing into the allegations made by Novartis on India's 'discriminatory' patent practices, the government has said global firms, including the Swiss drug major, have benefited more from the......

Novartis has 219 patents in India

India’s intent to respect intellectual property may have drawn international criticism following the Supreme Court’s decision on Glivec, but facts point at a different story.After Swiss......

Will not invest on R&D in India, says Novartis

Swiss pharma major Novartis said on Monday it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent......

Novartis India bullish on rural sales

Swiss drug major Novartis' Indian arm is upbeat about its rural sales initiative, Arogya Parviar and plans to double its reach in the country over the next few years. "Arogya Parivar that started......
  Videos for Novartis India
novartis india  video

  People speak for novartis india

  • QNA
Q. what about novartis india future??
:  A. bright.Stay invested. more

http://qna.rediff.com/questions-and-answers/what-about-novartis-india-future//answers/17914286

Lynnus babyangel
Q. when will swine flu vaccine come to india and whether govt will supply it free
Lynnus Babyangel:  A. It cannot be said with authority that when it will be made available, but it will not be far late now. Whether Free, can't say now. Some other...... more

http://qna.rediff.com/questions-and-answers/when-will-swine-flu-vaccine-come-to-india-and-whether-govt-w/17914266/answers/15560690

SOMASUNDARAM MAHADEVAN
Q. Can i buy this company because ameriacn company will take off this company Novartis India Ltdthe oppen offer star on may20 -june8can i go this company
SOMASUNDARAM MAHADEVAN:  A. + more

http://qna.rediff.com/questions-and-answers/can-i-buy-this-company-because-ameriacn-company-will-take-of/15560640/answers/14495700

shiva
Q. What should be fair price at which I should sell this stock?(Novartis). One of the associated company Syngenta India Ltd. offered around 500 as exit price initially, but ultimately ended up paying more then Rs.700 for the same script when offer was finalized.
Shiva :  A. For free stock tips, derivatives(Options Put & calls). Add- neenu_kothari@yahoo.com in messenger.Tips given weekly, daily with intraday targets.RegardsNeenu more

http://qna.rediff.com/questions-and-answers/what-should-be-fair-price-at-which-i-should-sell-this-stockn/14467582/answers/13835331

  Web results for Novartis India
Novartis shares up nearly 2% at close

MUMBAI: Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 per cent higher today, a day... ...

http://economictimes.indiatimes.com/markets/stocks/news/novartis-shares-up-nearly-2-at-close/articleshow/45630988.cms
Novartis India gains; competition watchdog approves GSK deal

Shares of Novartis India gained 2.8 per cent in trade today. The surge happened after Competition Commission of India approved deal between... ...

http://economictimes.indiatimes.com/markets/stocks/news/novartis-india-gains-competition-watchdog-approves-gsk-deal/articleshow/45625775.cms
Why the Tata Memorial incident should be a wake-up call for other hospitals, pharma companies and regulators

'A stitch in time saves nine' is a befitting phrase in the case of India's most reputed cancer speciality healthcare service provider, the Tata... ...

http://www.dnaindia.com/health/report-why-the-tata-memorial-incident-should-be-a-wake-up-call-for-other-hospitals-pharma-companies-and-regulators-2038126
Net sales of 50 major pharma cos up by 14%, EBDITA by 15.5% in first half of 2014-15

Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=85258&sid=1
Tata Memorial to repay cancer patients

Tata Memorial Hospital has decided to reimburse cancer patients who were overcharged for a Novartis-branded oncology medicine over the last nine... ...

http://www.dnaindia.com/mumbai/report-dna-impact-tata-memorial-to-repay-cancer-patients-2037613

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z